Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcysteine in Non-Acetaminophen Acute Liver Failure
NCT00004467Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jun 1998
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in acute liver failure (ALF), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jun 1998; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acute liver failure (ALF)
Beyond the preview
Go deeper on NCT00004467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004467.